Semantic Scholar uses AI to extract papers important to this topic.
Selective COX-2 inhibitors are non-steroidal anti-inflammatory drugs which directly target cyclooxygenase-2 (COX-2), an enzyme… Expand Iridium-catalyzed C–H activation and ortho-hydrogen isotope exchange is an important technology for allowing access to labeled… Expand Mavacoxib is a novel nonsteroidal anti-inflammatory drug (NSAID), with a preferential action on the cyclooxygenase (COX)-2… Expand A multi-site, masked, randomised parallel group study employing a double dummy treatment design was performed in canine… Expand BackgroundThe NSAID mavacoxib (Trocoxil™) is a recently described selective COX-2 inhibitor used for the management of… Expand NSAIDs are the cornerstone of medical management of canine osteoarthritis (OA). Meloxicam is a daily-administered NSAID widely… Expand Osteosarcoma is the most common primary bone tumour of both children and dogs. It is an aggressive tumour in both species with a… Expand Received: Revised: Accepted: October 11, 2012 December 12, 2012 December 17, 2012 The aim of this study was to assess the… Expand Mavacoxib (Trocoxil™) is an oral long-acting COX-2 inhibitor approved for the treatment of osteoarthritis in dogs. Two field… Expand The pharmacokinetics of mavacoxib were evaluated in an absolute bioavailability study, a dose-proportionality study and a multi… Expand